Caisse de depot et placement du Quebec Makes New $571.58 Million Investment in Merck KGaA $MKGAF

Key Points

• Caisse de dépôt et placement du Québec acquired 4.45 million shares of Merck KGaA in the second quarter, valued at approximately $571.6 million. The position represents about 3.44% of Merck KGaA and 0.8% of the fund’s portfolio.
• Several smaller institutional investors also initiated positions in Merck KGaA during the quarter, while institutional ownership was reported at 0.10%.
• Merck KGaA shares opened at $164, with a market capitalization of $21.2 billion and a price-to-earnings ratio of 25.04. The stock has traded between $116.68 and $175.56 over the past year and remains above its 200-day moving average.

Caisse de depot et placement du Quebec bought a new stake in shares of Merck KGaA (OTCMKTS:MKGAF - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 4,448,107 shares of the company's stock, valued at approximately $571,582,000. Merck KGaA comprises approximately 0.8% of Caisse de depot et placement du Quebec's portfolio, making the stock its 26th largest holding. Caisse de depot et placement du Quebec owned approximately 3.44% of Merck KGaA at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Frazier Financial Advisors LLC acquired a new stake in shares of Merck KGaA during the second quarter worth $25,000. Rakuten Securities Inc. acquired a new position in Merck KGaA in the second quarter valued at about $27,000. Solstein Capital LLC acquired a new position in Merck KGaA in the second quarter valued at about $33,000. Delos Wealth Advisors LLC bought a new position in Merck KGaA during the second quarter worth about $33,000. Finally, Burk Holdings LLC acquired a new position in shares of Merck KGaA during the 2nd quarter worth about $39,000. 0.10% of the stock is currently owned by institutional investors.

Merck KGaA Stock Performance

Shares of MKGAF stock opened at $164.00 on Wednesday. The stock has a market cap of $21.20 billion, a PE ratio of 25.04 and a beta of 0.96. The stock has a 50-day moving average of $163.08 and a 200-day moving average of $148.69. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a one year low of $116.68 and a one year high of $175.56.

Merck KGaA Company Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company's operations are organized mainly into three businesses.

Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source